Cox-Singh Janet, Davis Timothy M E, Lee Kim-Sung, Shamsul Sunita S G, Matusop Asmad, Ratnam Shanmuga, Rahman Hasan A, Conway David J, Singh Balbir
Malaria Research Centre, Faculty of Medicine and Health Sciences, University Malaysia Sarawak, Kuching, Sarawak, Malaysian Borneo.
Clin Infect Dis. 2008 Jan 15;46(2):165-71. doi: 10.1086/524888.
Until recently, Plasmodium knowlesi malaria in humans was misdiagnosed as Plasmodium malariae malaria. The objectives of the present study were to determine the geographic distribution of P. knowlesi malaria in the human population in Malaysia and to investigate 4 suspected fatal cases.
Sensitive and specific nested polymerase chain reaction was used to identify all Plasmodium species present in (1) blood samples obtained from 960 patients with malaria who were hospitalized in Sarawak, Malaysian Borneo, during 2001-2006; (2) 54 P. malariae archival blood films from 15 districts in Sabah, Malaysian Borneo (during 2003-2005), and 4 districts in Pahang, Peninsular Malaysia (during 2004-2005); and (3) 4 patients whose suspected cause of death was P. knowlesi malaria. For the 4 latter cases, available clinical and laboratory data were reviewed.
P. knowlesi DNA was detected in 266 (27.7%) of 960 of the samples from Sarawak hospitals, 41 (83.7%) of 49 from Sabah, and all 5 from Pahang. Only P. knowlesi DNA was detected in archival blood films from the 4 patients who died. All were hyperparasitemic and developed marked hepatorenal dysfunction.
Human infection with P. knowlesi, commonly misidentified as the more benign P. malariae, are widely distributed across Malaysian Borneo and extend to Peninsular Malaysia. Because P. knowlesi replicates every 24 h, rapid diagnosis and prompt effective treatment are essential. In the absence of a specific routine diagnostic test for P. knowlesi malaria, we recommend that patients who reside in or have traveled to Southeast Asia and who have received a "P. malariae" hyperparasitemia diagnosis by microscopy receive intensive management as appropriate for severe falciparum malaria.
直到最近,人类诺氏疟原虫疟疾一直被误诊为三日疟原虫疟疾。本研究的目的是确定马来西亚人群中诺氏疟原虫疟疾的地理分布,并调查4例疑似死亡病例。
采用灵敏且特异的巢式聚合酶链反应来鉴定存在于以下样本中的所有疟原虫种类:(1)2001年至2006年期间在马来西亚婆罗洲沙捞越住院的960例疟疾患者的血液样本;(2)来自马来西亚婆罗洲沙巴15个地区(2003年至2005年)以及马来西亚半岛彭亨4个地区(2004年至2005年)的54份三日疟原虫存档血片;(3)4例疑似因诺氏疟原虫疟疾死亡的患者。对于后4例病例,回顾了可用的临床和实验室数据。
在沙捞越医院的960份样本中有266份(27.7%)检测到诺氏疟原虫DNA,在沙巴的49份样本中有41份(83.7%)检测到,彭亨的所有5份样本均检测到。在4例死亡患者的存档血片中仅检测到诺氏疟原虫DNA。所有患者均为高疟原虫血症,并出现明显的肝肾损害。
人类感染诺氏疟原虫(通常被误诊为致病性较低的三日疟原虫)在马来西亚婆罗洲广泛分布,并延伸至马来西亚半岛。由于诺氏疟原虫每24小时复制一次,快速诊断和及时有效的治疗至关重要。在缺乏针对诺氏疟原虫疟疾的特异性常规诊断检测的情况下,我们建议居住在东南亚或前往过东南亚且通过显微镜检查被诊断为“三日疟原虫”高疟原虫血症的患者接受针对严重恶性疟原虫疟疾的适当强化治疗。